NEWS

December 21, 2020

Mesoblast shares savaged on poor COVID trial results

MELBOURNE: Stem cell biotech Mesoblast has had its share price smashed after the ... read more

December 21, 2020

RAM bulks up for float with triple hospital deal

SYDNEY: Real Asset Management (RAM) has reached its target of $500 million of ... read more

December 21, 2020

Suitors scan Capitol Health amid demand for healthcare assets

MELBOURNE: Diagnostic imaging provider Capitol Health is being touted as a likely takeover ... read more

December 21, 2020

Trajan hopes for a cash injection from investors

MELBOURNE: Medical device manufacturer Trajan is the latest company to make plans to ... read more